Monday's Final Takeaways: AZN/BMY Talks, SPCX Earnings Ahead
Community Score: 50% | 1.0K views | 1w
0 community ratings: null thumbs up, null thumbs down
Marley Kayden points to "Merger Monday" headlines in the biotech space as AstraZeneca (AZN) and Bristol Myers Squibb (BMY) could reportedly merge into a mega-company worth more than $400B. Sam Vadas looks overseas at the joint U.S.-Japan intervention on the yen currency. For tomorrow, Marley has her eyes on SpaceX (SPCX) earnings and Sam circles macro-data on her calendar including JOLTS with a first glimpse at July jobs data. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us
More from Schwab Network
- META's Path to $800: Jason Ware Sees Bull Case in AI ROI as CapEx Grows — Score: 50%
- "Tale of Two Chinas:" Hot AI Trade Meets Cooling Consumer Activity — Score: 50%
- Stock Market Today: MU Hits Highs, QCOM Deal & AAPL Falls — Score: 50%
- Strive CRO on Bitcoin's Buy Opportunity, Crypto Volatility & SATA — Score: 50%
- Thursday’s Final Takeaways: PCE, Markets & Tech in Focus — Score: 50%
- Bitcoin Breaks Key Technical Level as Crypto Awaits Regulatory Clarity — Score: 50%